Literature DB >> 20541486

Gastric adenocarcinoma and Helicobacter pylori: correlation with p53 mutation and p27 immunoexpression.

Angela Rosa André1, Márcia Valéria Pitombeira Ferreira, Rosa Maria Salani Mota, Adriana Camargo Ferrasi, Maria Inês de Moura Campos Pardini, Sílvia Helena Barem Rabenhorst.   

Abstract

INTRODUCTION: Helicobacter pylori infection is an established risk factor for gastric cancer development, but the exact underlying mechanism still remains obscure. The inactivation of tumor suppressor genes such as p53 and p27(KIP1) is a hypothesized mechanism, although there is no consensus regarding the influence of H. pylori cagA(+) in the development of these genetic alterations. GOALS: To verify the relationship among H. pylori infection, p53 mutations and p27(Kip1) Protein (p27) expression in gastric adenocarcinomas (GA) seventy-four tissues were assayed by PCR for H. pylori and cagA presence. Mutational analysis of p53 gene was performed by single-strand conformation polymorphism (SSCP). Seventy tissues were analyzed by an immunohistochemical method for p27 expression.
RESULTS: From the samples examined, 95% (70/74) were H. pylori positive, 63% cagA(+). Altered p53 electrophoretic mobility was found in 72% of cases and significantly more frequent in the presence of cagA. Considerable reduction in p27 expression (19%) was found with a tendency for association between cagA(+) and p27(-), although the results were not statistically significant. Concomitant alterations of both suppressor genes were detected in 60% of cases. In the cases cagA(+), 66.7% of them had these concomitant alterations.
CONCLUSIONS: The data suggest that H. pylori cagA(+) contributes to p53 alteration and indicate that concomitant gene inactivation, with reduced p27 expression, may be a mechanism in which H. pylori can promote the development and progression of gastric cancer.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20541486     DOI: 10.1016/j.canep.2010.05.005

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  6 in total

1.  Differential expression of MYC in H. pylori-related intestinal and diffuse gastric tumors.

Authors:  Isabelle Joyce de Lima Silva-Fernandes; Markênia Kélia Santos Alves; Valeska Portela Lima; Marcos Antônio Pereira de Lima; Marcos Aurélio Pessoa Barros; Márcia Valéria Pitombeira Ferreira; Silvia Helena Barem Rabenhorst
Journal:  Virchows Arch       Date:  2011-05-03       Impact factor: 4.064

2.  Detection of helicobacter pylori in benign laryngeal lesions by polymerase chain reaction: a cross sectional study.

Authors:  Farzad Izadi; Aslan Ahmadi; Shadi Ghourchian; Ahmad Daneshi; Faramarz Memari; Ehsan Khadivi; Shabahang Mohammadi
Journal:  Infect Agent Cancer       Date:  2012-04-19       Impact factor: 2.965

Review 3.  Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity.

Authors:  Shamshul Ansari; Boldbaatar Gantuya; Vo Phuoc Tuan; Yoshio Yamaoka
Journal:  Int J Mol Sci       Date:  2018-08-16       Impact factor: 5.923

4.  Association of p53 Gene Mutation With Helicobacter pylori Infection in Gastric Cancer Patients and Its Correlation With Clinicopathological and Environmental Factors.

Authors:  M Mizanur Rahman; M Abu Kawsar Sarker; Md Monowar Hossain; Mohd Sahajadul Alam; Md Monzurul Islam; Laila Shirin; Rokeya Sultana; Gazi Nurun Nahar Sultana
Journal:  World J Oncol       Date:  2019-02-26

Review 5.  The microbiome and prostate cancer.

Authors:  Juan Javier-DesLoges; Rana R McKay; Austin D Swafford; Gregory D Sepich-Poore; Rob Knight; J Kellogg Parsons
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-07-15       Impact factor: 5.455

6.  Whole Genome Sequencing Reveals Virulence Potentials of Helicobacter pylori Strain KE21 Isolated from a Kenyan Patient with Gastric Signet Ring Cell Carcinoma.

Authors:  Catherine Mwangi; Stephen Njoroge; Evariste Tshibangu-Kabamba; Zahir Moloo; Allan Rajula; Smita Devani; Takashi Matsumoto; Kimang'a Nyerere; Samuel Kariuki; Gunturu Revathi; Yoshio Yamaoka
Journal:  Toxins (Basel)       Date:  2020-08-29       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.